$MDXL - News on official launch of versatile new healthcare

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
335
$MDXL - News on official launch of versatile new healthcare services platform to serve a wide range of patients.

GetHealthKarma.com Now Launched by MediXall Group

Fort Lauderdale, FL, Nov. 17, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- MediXall Group, Inc. (OTCQB: MDXL), a consumer-focused digital health company, today announced the launch of Health Karma – a comprehensive new tool to enable consumers to easily navigate their health and wellness experience. Designed over several years of listening to the needs of individuals and developed to put the individual at the center, Health Karma offers support that revolves around the unique needs of each person when they’re either sick or healthy, when and how they need it most.

Consumer feedback from extensive user testing over several years has revealed consumer confusion and lack of understanding with respect to how much healthcare services will cost, which doctors consumers should choose, what procedures or prescriptions may be required, and a general inability to make informed decisions about care because there is no single source or repository of information. The following are the most the most common pain points we identified from user feedback:

What will insurance cover? Consumers aren’t sure about the network status of their doctors, which conflicts with the need to see an in-network doctor to avoid very expensive medical bills.
How much will insurance pay? Consumers do not know or understand their health plan coverage details and have trouble determining if it will cover everything, up to a specific limit or nothing until a deductible is met.
What are the out-of-pocket costs? Lack of understanding if their health insurance requires them to pay a portion of charges out of their own pocket.
Know what you owe. Many times, consumers are surprised by how much is owed for services due to their lack of understanding about how much is owed for medical services and if the amount is a fair price.
Will you have the money you need? Consumers feel financial and emotional pressure when it comes to making sure they have money available to pay for services.

Aligned with the feedback gathered during the beta launch, Health Karma gives consumers a 360-degree view of their personal health with the educational tips, tools, and guidance needed to make informed decisions based on their personal health needs. Health Karma shifts peoples’ approach to care from reactive to proactive, enabling them to make smarter and faster decisions and manage their healthcare anywhere, anytime, whether they have insurance or not.

With Health Karma, users can:

Talk to a Doctor Virtually, 24/7/365
Find a Healthcare Provider or Facility
Track and Review Current Plan Usage - All in Real-Time
Estimate Out-of-pocket Costs
Find Rx Savings
Access & Send Medical Records
Get Immediate Help with Customer Support and Get Questions Answered
In announcing this launch, Michael Swartz, President of Health Karma, a division of MediXall Group said, “As the number of Americans with high-deductible health plans continue to increase, consumers are assuming more responsibility for their health care costs, and they need accurate and easy-to-navigate tools to help them make the right decisions for their care. Unfortunately, the health care consumer has been forced to use one-off tools that are often inaccurate or hard to navigate. That is why we built Health Karma to offer an integrated experience that empowers them with the right information at the right time, enabling them to make the best decisions along their healthcare journey.”

To learn more about Health Karma or to sign up for a Health Karma account, please visit http://www.gethealthkarma.com.

About MediXall Group, Inc.
MediXall Group, Inc. (OTCQB: MDXL) is a technology and innovation-driven organization purposefully designed and structured around delivering products and services to make it easier for consumers to learn, decide and pay for healthcare, without intruding on the important relationship with trusted doctors. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. By approaching the healthcare ecosystem as a whole, MediXall creates, invests and incubates companies that embody its mission statement. For more information, please visit http://www.medixallgroup.com or call 954-908-3481.

About Health Karma
Health Karma is the technology company that brings price transparency and choice to healthcare, eliminating financial surprises and empowering people to make more informed decisions - with or without health insurance. Powered by a comprehensive database that includes over 1 million doctors in America & connected to thousands of health insurance policies nationwide, Health Karma makes health care & benefits easy to understand and use throughout your entire health journey – From choosing a doctor and managing bills to understanding their benefits and tracking the progress toward meeting their deductible and out-of-pocket maximum, consumers can manage their healthcare anywhere, anytime, whether they have insurance or not. For more information, please visit http://www.gethealthkarma.com.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company’s current plans and expectations, as well as future results of operations and financial condition. Specifically, the Company’s ability to raise additional capital, execute its business plan and strategy, sustain or increase gross margins, achieve profitability and build shareholder value are forward-looking statements. A more extensive listing of risks and factors that may affect the Company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the Company with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Rebecca Larger

786-886-4681

r.larger@waxcom.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 209

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Marina Genova Joins SEA Index to Promote Sustainable Yachting

Updated Category News Views 173

Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....

Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know

Updated Category News Views 2610

Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...

Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 50

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution

Updated Category News Views 210

So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...

Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70

Updated Category News Views 242

JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....

Continue Reading